Bulk Manufacturer of Controlled Substances Registration, 5500 [2019-02868]
Download as PDF
<![CDATA[
5500
Federal Register / Vol. 84, No. 35 / Thursday, February 21, 2019 / Notices
Company
FR docket
Chattem Chemicals ..........................................................
83 FR 56103 ...................................................................
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
Dated: January 29, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–02867 Filed 2–20–19; 8:45 am]
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule II controlled substances.
The
company listed below applied to be
registered as a bulk manufacturer of
various basic classes of controlled
substances. Information on a previously
published notice is listed below. No
comments or objections were submitted
for the notice.
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
FR docket
Janssen Pharmaceuticals, Inc ..........................................
83 FR 55205 ...................................................................
registration as a bulk manufacturer to
the above listed company.
Dated: January 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–02868 Filed 2–20–19; 8:45 am]
BILLING CODE 4410–09–P
Published
November 2, 2018.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
schedule I or schedule II controlled
substances.
SUMMARY:
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on the previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
November 9, 2018.
SUMMARY:
Company
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
amozie on DSK3GDR082PROD with NOTICES1
registration as a bulk manufacturer to
the above listed company.
Published
Notice of registration.
Company
FR docket
Mylan Pharmaceuticals, Inc .........................................................................................................................
Siegfried USA, LLC ......................................................................................................................................
83 FR 64158
83 FR 64158
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
VerDate Sep<11>2014
17:08 Feb 20, 2019
Jkt 247001
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted registrations as importers for
schedule II controlled substances to the
above listed companies.
PO 00000
Frm 00097
Fmt 4703
Sfmt 9990
Published
December 13, 2018.
December 13, 2018.
Dated: January 29, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–02874 Filed 2–20–19; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\21FEN1.SGM
21FEN1
]]>Agencies
[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Page 5500]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02868]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and been granted
registration by the Drug Enforcement Administration (DEA) as a bulk
manufacturer of various classes of schedule II controlled substances.
SUPPLEMENTARY INFORMATION: The company listed below applied to be
registered as a bulk manufacturer of various basic classes of
controlled substances. Information on a previously published notice is
listed below. No comments or objections were submitted for the notice.
------------------------------------------------------------------------
Company FR docket Published
------------------------------------------------------------------------
Janssen Pharmaceuticals, Inc.. 83 FR 55205........... November 2,
2018.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of this registrant to manufacture the
applicable basic classes of controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed company.
Dated: January 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-02868 Filed 2-20-19; 8:45 am]
BILLING CODE 4410-09-P
